Floatz logo

LIDOCAINE

Migraine With Typical Aura

Corona Doctors Medical Clinics, Inc.Small moleculePhase 1/2Dormant
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

22 Active assets in the Migraine With Typical Aura cohort.

Asset / SponsorPhaseRating
Topamax
Tongji Hospital
Phase 4BBB
Dihydroergotamine mesylate
Satsuma Pharmaceuticals, Inc.
Phase 3BB
PROPRANOLOL
Norwegian University of Science and Technology
Phase 3BB
Rimegepant
University of South Florida
Phase 4BB
ALMOTRIPTAN
Messoud Ashina, MD
Phase 4BB

View all 49 →

Same molecule, other indications

LIDOCAINE is also rated in:

peripheral neuropathyDormant
BBB
Indicative ·
79 / 100
View asset →
postherpetic neuralgiaDormant
BBB
Indicative ·
78 / 100
View asset →
post-operative pain, non-human animalDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →